Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.64% |
| Dec 31, 2025 | -22.71% |
| Sep 30, 2025 | 9.12% |
| Jun 30, 2025 | -1.99% |
| Mar 31, 2025 | -5.04% |
| Dec 31, 2024 | -16.24% |
| Sep 30, 2024 | 13.89% |
| Jun 30, 2024 | -165.88% |
| Mar 31, 2024 | 12.36% |
| Dec 31, 2023 | -21.85% |
| Sep 30, 2023 | 11.80% |
| Jun 30, 2023 | 2.99% |
| Mar 31, 2023 | 3.33% |
| Dec 31, 2022 | 34.22% |
| Sep 30, 2022 | 41.85% |
| Jun 30, 2022 | 34.95% |
| Mar 31, 2022 | 43.32% |
| Dec 31, 2021 | 46.79% |
| Sep 30, 2021 | 34.47% |
| Jun 30, 2021 | -37.87% |
| Mar 31, 2021 | 53.90% |
| Dec 31, 2020 | 29.28% |
| Sep 30, 2020 | 74.76% |
| Jun 30, 2020 | 78.81% |
| Mar 31, 2020 | 45.34% |
| Dec 31, 2019 | 45.52% |
| Sep 30, 2019 | 72.12% |
| Jun 30, 2019 | 124.73% |
| Mar 31, 2019 | 186.26% |
| Dec 31, 2018 | 121.00% |
| Sep 30, 2018 | 101.19% |
| Jun 30, 2018 | 70.05% |
| Mar 31, 2018 | 46.39% |
| Dec 31, 2017 | 48.15% |
| Sep 30, 2017 | 57.95% |
| Jun 30, 2017 | 50.66% |
| Mar 31, 2017 | 52.00% |
| Dec 31, 2016 | 94.20% |
| Sep 30, 2016 | 89.32% |
| Jun 30, 2016 | 258.51% |
| Mar 31, 2016 | 38.72% |
| Dec 31, 2015 | -10.43% |
| Sep 30, 2015 | -37.26% |
| Jun 30, 2015 | -43.11% |
| Mar 31, 2015 | -327.65% |
| Dec 31, 2014 | -33.16% |
| Sep 30, 2014 | -59.31% |
| Mar 31, 2014 | 1.98% |
| Dec 31, 2013 | 28.44% |
| Sep 30, 2013 | 56.26% |
| Jun 30, 2013 | 79.58% |
| Mar 31, 2013 | 30.56% |
| Dec 31, 2012 | 33.82% |
| Sep 30, 2012 | 90.36% |
| Jun 30, 2012 | 44.27% |
| Mar 31, 2012 | 26.32% |